IDENTIFICATION OF POTENTIAL DRUG-DRUG INTERACTIONS IN CARDIOLOGY DEPARTMENT IN A TERTIARY CARE HOSPITAL
Riya Sara Reji*, Aqueena George, Niketha Vikraman, Ann Mariya Augustine, Lekshmi Gayathri and Praveen Kumar
Abstract
Background: DDI can be defined as interaction between two or more
drugs, resulting in either synergistic or antagonistic or idiosynergestic
effect of the drugs. A DDIs is a major concern in patients with CVD
due to multiple co-existing conditions and because of the wide class of
drugs they receive. Other risk factors such as age, polypharmacy,
pharmacokinetics and pharmacodynamics profile of drugs also alters
the overall therapeutic response which results in increased hospital stay
and health care cost. Objective: (1) To identify the PDDIs in the
Department of Cardiology in a Tertiary care hospital. (2) To assess the
data collected and describe the drugs, drug combinations and severity
associated with these interactions. Method: The proposed prospective
study was conducted over 150 patients of Cardiology department in
Aster CMI hospital, Bangalore using the Lexicomp Interct ® app for duration of 6 months.
Result: A total of 150 patients were included in the study. 503 interactions were identified
among 142 patients. The incidence of pDDIs was 94.6%.The most common pDDIs were
between Heparin & Ticagrelor (10.33%), Aspirin& Heparin (9.14%) and Atorvastatin &
Ticagrelor (7.95%). Majority of interactions were of moderate severity and of risk
classification C which required therapy monitoring. Conclusion: The data was collected to
identify the pDDIs. The present study identifies the need for screening prescriptions of cardiovascular patients for pDDIs, monitoring of these patients and usage of Online DDI database to prevent these interactions.
Keywords: ADR-Adverse drug reactions, PDDI-Potential drug drug interactions, CVD-Cardiovascular disease.
[Full Text Article]